Pharmacokinetics of buprenorphine following constant rate infusion for postoperative analgesia in dogs undergoing ovariectomy. (May 2017)
- Record Type:
- Journal Article
- Title:
- Pharmacokinetics of buprenorphine following constant rate infusion for postoperative analgesia in dogs undergoing ovariectomy. (May 2017)
- Main Title:
- Pharmacokinetics of buprenorphine following constant rate infusion for postoperative analgesia in dogs undergoing ovariectomy
- Authors:
- Barbarossa, Andrea
Rambaldi, Julie
Giunti, Massimo
Zaghini, Anna
Cunto, Marco
Zambelli, Daniele
Valgimigli, Simond
Santoro, Francesco
Romagnoli, Noemi - Abstract:
- Abstract: Objective: To investigate the pharmacokinetics of buprenorphine and its main active metabolite, norbuprenorphine, after administration of an intravenous loading dose followed by constant rate infusion (CRI) in dogs. Study design: Prospective, clinical study. Animals: A total of seven healthy dogs undergoing elective ovariectomy. Methods: Buprenorphine was administered as a loading dose (intravenous bolus of 15 μg kg −1 ) followed by CRI (2.5 μg kg −1 hour −1 for 6 hours). Moreover, intraoperative analgesia was supplemented by an intramuscular carprofen (4 mg kg −1 ) injection, administered prior to surgery, and by lidocaine, administrated through subcutaneous infiltration and through a splash on the ovarian vascular pedicle during surgery. Pain and sedation were scored for all animals throughout the 24-hour study period and rescue analgesia was administered when a visual analogue scale score was > 40 mm. Blood samples were collected from a jugular catheter at regular intervals, and plasma concentrations of buprenorphine and norbuprenorphine were determined by a validated liquid chromatography–tandem mass spectrometry method. Results: Buprenorphine showed a two-compartment kinetic profile. Maximum concentration was 23.92 ± 8.64 ng mL −1 at 1 minute (maximum time); elimination half-life was 41.87 ± 17.35 minutes; area under the curve was 486.68 ± 125.66 minutes ng −1 mL −1 ; clearance was 33.61 ± 13.01 mL minute −1 kg −1, and volume of distribution at steady stateAbstract: Objective: To investigate the pharmacokinetics of buprenorphine and its main active metabolite, norbuprenorphine, after administration of an intravenous loading dose followed by constant rate infusion (CRI) in dogs. Study design: Prospective, clinical study. Animals: A total of seven healthy dogs undergoing elective ovariectomy. Methods: Buprenorphine was administered as a loading dose (intravenous bolus of 15 μg kg −1 ) followed by CRI (2.5 μg kg −1 hour −1 for 6 hours). Moreover, intraoperative analgesia was supplemented by an intramuscular carprofen (4 mg kg −1 ) injection, administered prior to surgery, and by lidocaine, administrated through subcutaneous infiltration and through a splash on the ovarian vascular pedicle during surgery. Pain and sedation were scored for all animals throughout the 24-hour study period and rescue analgesia was administered when a visual analogue scale score was > 40 mm. Blood samples were collected from a jugular catheter at regular intervals, and plasma concentrations of buprenorphine and norbuprenorphine were determined by a validated liquid chromatography–tandem mass spectrometry method. Results: Buprenorphine showed a two-compartment kinetic profile. Maximum concentration was 23.92 ± 8.64 ng mL −1 at 1 minute (maximum time); elimination half-life was 41.87 ± 17.35 minutes; area under the curve was 486.68 ± 125.66 minutes ng −1 mL −1 ; clearance was 33.61 ± 13.01 mL minute −1 kg −1, and volume of distribution at steady state was 1.77 ± 0.50 L kg −1 . In no case was rescue analgesia required. Norbuprenorphine resulted below the lower limit of quantification in almost all samples. Conclusions and clinical relevance: The results suggest that a buprenorphine CRI can be a useful tool for providing analgesia in postoperative patients, considering its minor side effects and the advantages of a CRI compared to frequent boluses. The negligible contribution of norbuprenorphine to the therapeutic effect was confirmed. … (more)
- Is Part Of:
- Veterinary anaesthesia and analgesia. Volume 44:Number 3(2017)
- Journal:
- Veterinary anaesthesia and analgesia
- Issue:
- Volume 44:Number 3(2017)
- Issue Display:
- Volume 44, Issue 3 (2017)
- Year:
- 2017
- Volume:
- 44
- Issue:
- 3
- Issue Sort Value:
- 2017-0044-0003-0000
- Page Start:
- 435
- Page End:
- 443
- Publication Date:
- 2017-05
- Subjects:
- buprenorphine -- continuous rate infusion -- dog -- liquid chromatography–tandem mass spectrometry -- pharmacokinetics
Veterinary anesthesia -- Periodicals
636.089 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1467-2995 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1016/j.vaa.2016.05.010 ↗
- Languages:
- English
- ISSNs:
- 1467-2987
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 9226.528500
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 12276.xml